NCT07726966Not yet recruiting
Betacyanin for Early Diagnosis and Recovery of Anastomotic Leakage After Rectal Cancer Surgery: A Single-Center, Prospective, Controlled Trial
A Single - Center, Prospective,Controlled Clinical Trial Exploring the Function of Betacyanin in the Early Diagnosis and Subsequent Recovery From Anastomotic Leakage After Rectal Cancer Surgery
Source: ClinicalTrials.gov · Last updated 27 Jul 2026
Brief summary (registry, in English)
This single-center, prospective, controlled trial compares betacyanin versus conventional methods for early diagnosis and healing assessment of anastomotic leakage after rectal cancer surgery.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 21 Jul 2026
- Start date
- 20 Aug 2026
- Primary completion date
- 1 May 2027
- Lead sponsor
- Southwest Hospital, China
- Diseases
- Colorectal cancer
- NCT number
- NCT07726966
What you commit to
- Study type: Interventional
- Planned participants: 120
- From 20 Aug 2026 to the primary completion date, 1 May 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior abdominal surgery with severe intra-abdominal adhesions.
Other illness
- Currently participating in, or having participated within the past 6 months in, another clinical study related to rectal cancer surgery.
- Preoperative complications requiring emergency surgery, including bleeding, perforation, or obstruction.
- History of prior malignancy.
Other
- Undergoing Parks procedure with anastomosis at the anal verge, or Miles procedure, or Hartmann's procedure.
- Preoperative neoadjuvant chemoradiotherapy, or presence of other high-risk factors for anastomotic leakage requiring a prophylactic diverting ileostomy.
- ASA Physical Status Classification \> 3.
- Patient withdrawal of consent.
Who the study is looking for
- Pathologically confirmed rectal adenocarcinoma prior to surgery.
- Undergoing laparoscopic anterior resection for rectal cancer.
- No prophylactic diverting ileostomy.
- American Society of Anesthesiologists (ASA) Physical Status Classification ≤ 3.
- No prior history of malignant tumors, and no evidence of other malignancies on preoperative examination.
- Written informed consent obtained from the patient or a legally authorized representative.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| General Surgery Center of PLA Coordinator of this site? Confirm its status | Chongqing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.